OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $953,518 Invested

2016

Tetra Therapeutics Inc.

Mark Gurney, PhD

BPN14770 Safety and Cognitive Benefit in Young and Elderly Subjects

  • Funding Amount: $953,518
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed